Application of the "inverted chirality columns approach" for the monitoring of asymmetric synthesis protocols.

In the present study, the "Inverted Chirality Columns Approach (ICCA)" was applied to follow an asymmetric synthetic reaction, namely, the addition of butan-2-one to trans-β-nitrostyrene, catalysed by (S)-proline, leading to the formation of 3-methyl-4-phenyl-5-nitro-2-pentan-2-one. The ICCA method was applied to overcome the lack of pure enantiomeric standards. The two widely employed (R,R)- and (S,S)-Whelk-O1 chiral stationary phases (CSPs), incorporating fully synthesized enantiomeric chiral selectors, were profitably used for this purpose. The enantioselective analysis with the two CSPs was performed under optimized reversed-phase conditions with a water/acetonitrile (60/40, v/v) eluent. In the probe reaction under investigation, a diastereomeric excess >90% was found according to a well-established reaction mechanism, thus affording the enantiomer couple (3S,4R)-3-methyl-4-phenyl-5-nitropentan-2-one and (3R,4S)-3-methyl-4-phenyl-5-nitropentan-2-one as the main product. Therefore, the attention was exclusively focused on this enantiomers pair. Rather similar retention and separation factor [1.12 with (R,R)-Whelk-O1 and 1.13 with (S,S)-Whelk-O1] values as well as resolutions [2.06 with (R,R)-Whelk-O1 and 2.30 with (S,S)-Whelk-O1] were produced by the two enantiomeric CSPs. Applying the ICCA concept allowed to identify the two enantiomers-related peaks in the chromatograms, ultimately indicating a 65-to-35 enantiomeric per cent ratio. Electronic circular dichroism (ECD) and high-resolution mass spectrometry analyses of the two peaks collected during the enantioselective analyses further confirmed the enantiomeric nature of the identified compounds. The (3S,4R) < (3R,4S) enantiomer elution order with the (R,R)-Whelk-O1 was fully disclosed thanks to ECD studies coupled with in silico quantum mechanical simulations. As expected, reversed elution order turned out with (S,S)-Whelk-O1.

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.